AdvaMed®’s Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Coverage & Payment
Learn more about our Payment & Health Care Delivery Policy work.
Impact of FDA Changes on Medtech Research
On April 3, NAMSA hosts a webinar with Dr. Jeff Shuren, former FDA CDRH Director, discussing FDA changes impacting Medtech development. RSVP today.
Richardson Waiver Repeal: What it Means for Medtech
Sidley Austin, joined by HPA, will lead a program examining the impact of HHS repealing the so-called “Richardson Waiver”, including its history, how it could impact the activities of the…
The Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
The Impact of Tariffs on Patient Access to Medical Technology
Tariffs on medtech could disrupt supply chains, increase costs, and delay care. Exemptions are needed to protect hospitals, patients, and innovation.
AdvaMed® Payment Policy Forum
Gain insights from thought leaders and industry experts as they delve into medtech payment policies, private payer challenges and more.
AdvaMed® Welcomes Bipartisan Senate Bill to Expedite Medicare Coverage of Breakthrough Medical Technologies, Diagnostic Tests
AdvaMed®, the Medtech Association, today welcomed introduction in the U.S. Senate of bipartisan legislation to expedite Medicare coverage of FDA-“breakthrough”-designated medical technologies and diagnostic tests. The legislation, the Ensuring Patient…
AdvaMed®: Final CMS Payment Rules Contain Significant Victories for Patients
AdvaMed®, the Medtech Association, today said two new final payment rules from the Centers for Medicare and Medicaid Services (CMS) for 2025 contain several important provisions that will improve access…
AdvaMed® Calls on Medicare to Cover Supplemental Imaging as Part of Breast Cancer Screening
AdvaMed®, the Medtech Association, called on Medicare in a letter sent Friday to cover supplemental imaging for women with heterogeneously and extremely dense breast tissue, noting the life-saving value of…
AdvaMed®: Final CMS Hospital Outpatient Payment Rule Contains Significant Improvement for Patient Access to Care
WASHINGTON – AdvaMed®, the Medtech Association, today praised The Centers for Medicare and Medicaid Services (CMS) Hospital Outpatient Prospective Payment System (HOPPS) and Ambulatory Surgical Center Payment System rule for…